Cite
Clinical and prognostic significance of serum levels of von Willebrand factor and ADAMTS-13 antigens in AL amyloidosis
MLA
Kastritis, E.Papassotiriou, I.Terpos, E.Roussou, M.Gavriatopoulou, M.Komitopoulou, A.Skevaki, C.Eleutherakis-Papaiakovou, E.Pamboucas, C.Psimenou, E.Manios, E.Giannouli, S.Politou, M.Gakiopoulou, H.Papadopoulou, E.Stamatelopoulos, K.Tasidou, A.Dimopoulos, M. A. Clinical and Prognostic Significance of Serum Levels of von Willebrand Factor and ADAMTS-13 Antigens in AL Amyloidosis. Jan. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......2127..18371e25938092ffaab2d09490ebcb5c&authtype=sso&custid=ns315887.
APA
Kastritis, E. P. I. T. E. R. M. G. M. K. A. S. C. E.-P. E. P. C. P. E. M. E. G. S. P. M. G. H. P. E. S. K. T. A. D. M. A. (2016). Clinical and prognostic significance of serum levels of von Willebrand factor and ADAMTS-13 antigens in AL amyloidosis.
Chicago
Kastritis, E. Papassotiriou, I. Terpos, E. Roussou, M. Gavriatopoulou, M. Komitopoulou, A. Skevaki, C. Eleutherakis-Papaiakovou, E. Pamboucas, C. Psimenou, E. Manios, E. Giannouli, S. Politou, M. Gakiopoulou, H. Papadopoulou, E. Stamatelopoulos, K. Tasidou, A. Dimopoulos, M.A. 2016. “Clinical and Prognostic Significance of Serum Levels of von Willebrand Factor and ADAMTS-13 Antigens in AL Amyloidosis,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......2127..18371e25938092ffaab2d09490ebcb5c&authtype=sso&custid=ns315887.